EPA is the omega-3 fatty acid most strongly linked to dry eye relief. A 2023 meta-analysis found that higher EPA percentages in supplements correlated with greater reductions in dry eye symptoms, and most successful clinical trials use a 2:1 ratio of EPA to DHA. But the type of omega-3 matters almost as much as the form it comes in and how long you take it.
Why EPA Matters More Than DHA
Both EPA and DHA are long-chain omega-3 fatty acids found in marine sources, and both play a role in reducing inflammation. But when researchers analyzed data across multiple trials, the percentage of EPA in a supplement showed a stronger correlation with symptom improvement than DHA alone. The mechanism comes down to how your body uses each one: EPA is more directly involved in producing anti-inflammatory signaling molecules, while DHA plays a larger structural role in cell membranes.
For dry eyes specifically, omega-3s work on the tiny oil-producing glands along your eyelid margins called meibomian glands. These glands secrete the oily outer layer of your tear film that keeps tears from evaporating too quickly. Lab research shows that omega-3 fatty acids stimulate these gland cells to produce more lipid-rich droplets, increasing triglyceride content by 2.4 to 3.7 times. This can improve both the quality and quantity of the oil layer, reducing the gland blockages that are a leading cause of dry eye.
The Dosage Most Trials Use
The most commonly studied dose is 2,000 mg of EPA plus 1,000 mg of DHA per day, totaling 3,000 mg of combined omega-3s. This was the dose used in the largest randomized trial on dry eye (535 patients) and is the benchmark most eye care professionals reference. Smaller trials have tested lower ranges, from roughly 325 to 720 mg of EPA with 175 to 480 mg of DHA, and still found measurable improvements in tear stability and symptoms over one to six months.
If you’re checking supplement labels, look at the EPA and DHA content per serving, not the total fish oil amount. A standard 1,000 mg fish oil capsule often contains only 300 to 400 mg of combined EPA and DHA. Reaching 3,000 mg of active omega-3s typically requires a concentrated formula or multiple capsules per day. Expect to spend around $60 per 90-day supply at therapeutic doses.
Krill Oil vs. Fish Oil
A randomized trial directly compared krill oil and fish oil head-to-head for dry eye, and the results were nuanced. Both forms reduced tear osmolarity (a key marker of dry eye severity) by about the same amount after 90 days: roughly 19 mOsmol/L compared to almost no change with placebo. Both also improved tear stability and reduced eye redness.
Where krill oil pulled ahead was in symptom scores and inflammation. Only the krill oil group saw a statistically significant improvement in patient-reported symptoms compared to placebo. Krill oil also reduced levels of a specific inflammatory marker in tears (interleukin 17A) by about 27 units, while the placebo group’s levels actually increased by nearly 47 units. The likely explanation is that omega-3s in krill oil are bound to phospholipids rather than triglycerides, which may improve how they’re absorbed and delivered to inflamed tissues.
That said, fish oil still produced meaningful improvements in the objective measures of dry eye. If cost or availability is a factor, fish oil at adequate doses remains a solid option.
Triglyceride Form Absorbs Better
Beyond the source (fish vs. krill), the chemical form of your supplement affects how well your body absorbs it. Omega-3 supplements come in three main forms: ethyl ester (EE), triglyceride (TG), and re-esterified triglyceride (rTG).
Most inexpensive fish oil capsules use the ethyl ester form, which is created during chemical concentration. Re-esterified triglyceride is a more processed version that converts the omega-3s back into a natural triglyceride structure. Multiple studies have found that the triglyceride form has superior bioavailability compared to ethyl esters, meaning more of what you swallow actually reaches your bloodstream. The rTG form also causes fewer gastrointestinal side effects like fishy burps, nausea, and stomach discomfort, which matters when you’re taking high doses daily for months.
When shopping, look for “triglyceride form” or “rTG” on the label. Some brands advertise this prominently; others require checking the fine print or contacting the manufacturer.
How Long Before You Notice a Difference
Omega-3 supplements are not a quick fix. Clinical trials measure outcomes anywhere from six weeks to twelve months, and the meta-regression data is clear: longer supplementation produces better results across nearly every measure, including symptom scores, tear stability, tear production, and tear osmolarity. Most patients in trials begin to see measurable changes around the three-month mark, which is why 90 days is the most common study endpoint.
The practical takeaway is to commit to at least three months of consistent daily supplementation before judging whether it’s working. Some people notice improvements in comfort and reduced grittiness within four to six weeks, but the full effect on meibomian gland function and tear film quality takes longer to develop. If you stop early, you may miss the benefit entirely.
Putting It Together
The strongest evidence points to a supplement with a high EPA-to-DHA ratio (at least 2:1), in a triglyceride or re-esterified triglyceride form, at a daily dose of at least 2,000 mg EPA and 1,000 mg DHA. Krill oil may offer an edge in symptom relief and inflammation reduction, though it can be more expensive per milligram of omega-3. Whatever form you choose, consistency over at least three months matters more than any single product feature.